Company Overview and News

 
Decmil posts net loss, reshuffles board

2018-02-28 businessnews.com.au
Decmil Group has launched a major board restructure that includes the retirement of company founder Denis Criddle, as it posted an interim loss but pointed to strong revenue growth in the coming year.
Upvote Downvote

 
Decmil posts net loss, board reshuffle

2018-02-28 businessnews.com.au
Decmil Group has commenced a major board restructure that includes retirement of company founder Denis Criddle, as it posted an interim loss but pointed to strong revenue growth in the coming year.
Upvote Downvote

 
Decmil wins $37m work

2018-02-09 businessnews.com.au
Decmil Group has been awarded two contracts totalling $37 million for road construction work in Victoria, which includes $29 million worth of work for VicRoads.
Upvote Downvote

 
Retail records continue to tumble

2017-12-05 theage.com.au
Fierce competition for a Toorak shop – for sale for the first time in 40 years – pushed its price to $3.75 million, about $1.5 million over the reserve. Teska Carson's Michael Taylor and Tom Maule said 595 Malvern Road was knocked down at auction to an investor on a passing yield of just 1.8 per cent. "A keen contest was expected but the result surpassed our most optimistic expectations," Mr Taylor said.
Upvote Downvote

 
Retail records continue to tumble

2017-12-05 smh.com.au
Fierce competition for a Toorak shop – for sale for the first time in 40 years – pushed its price to $3.75 million, about $1.5 million over the reserve. Teska Carson's Michael Taylor and Tom Maule said 595 Malvern Road was knocked down at auction to an investor on a passing yield of just 1.8 per cent. "A keen contest was expected but the result surpassed our most optimistic expectations," Mr Taylor said.
Upvote Downvote

 
Decmil signs MOU for $275m solar contract

2017-12-05 businessnews.com.au
Decmil Group is well placed to secure a $275 million engineering contract for Chinese group Maoneng's 250-megawatt Sunraysia solar project in NSW, after signing a memorandum of understanding to complete early designs for the project.
Upvote Downvote

 
Decmil strong chance for $275m solar contract

2017-12-05 businessnews.com.au
Decmil Group is well placed to secure a $275 million engineering contract for Maoneng Australia’s 250 mega-watt Sunraysia solar project in New South Wales after signing a memorandum of understanding to complete early designs for the project.
Upvote Downvote

 
Decmil wins $60m of new work with VicRoads

2017-10-11 businessnews.com.au
Decmil Group has won more work on a highway extension project in Victoria, with the new package worth about $60 million.
Upvote Downvote

 
Decmil wins more work with VicRoads

2017-10-11 businessnews.com.au
Decmil Group has won more work on a highway extension project in Victoria, with the new package worth about $60 million.
Upvote Downvote

 
Decmil wins BHP contract

2017-08-17 businessnews.com.au
Decmil Group has announced the award of a $13 million contract for work at BHP Billiton's South Flank iron ore project near Newman.
Upvote Downvote

 
Decmil preferred for NZ prison work

2017-08-04 businessnews.com.au
Decmil Group has been earmarked for a $NZ60 million ($A56 million) construction contract for work at two prison sites in New Zealand.
Upvote Downvote

 
SCEE wins more work

2017-05-24 businessnews.com.au
Perth-based contractor Southern Cross Electrical Engineering has won $25 million in contracts for work on Rio Tinto’s Amrun bauxite project in Queensland, bringing its total number of awards for the month to about $150 million.
Upvote Downvote

 
Decmil sells property for $27m

2017-05-15 businessnews.com.au
Engineering and construction contractor Decmil Group has sold a commercial property near its Osborne Park headquarters to Primewest Funds for $27.5 million.
Upvote Downvote

 
Decmil in solar JV deal

2017-03-29 businessnews.com.au
Decmil Group has entered into a joint venture agreement with US-based SolarReserve for the construction of a 70 megawatt solar photovoltaic plant in NSW.
Upvote Downvote

 
Decmil scales back forecasts

2017-01-31 businessnews.com.au
Decmil Group has substantially cut its revenue forecasts for the current financial year due to delays in recent contract wins, while suffering further losses at a Victorian construction project.
Upvote Downvote

Related Articles

LPCN: Lipocine Inc Analysis and Research Report

11h - Asif

Overview Lipocine is a specialty pharmaceutical company focused on applying its oral drug delivery technology for the development of pharmaceutical products in the area of men’s and women’s health. The company's proprietary delivery technologies are designed to improve patient compliance and safety through orally available treatment options. The company's primary development programs are based on oral delivery solutions for poorly bioavailable drugs. Lipocine has a portfolio of proprietary product candidates designed to produce favorable pharmacokinetic (“PK”) characteristics and facilitate lower dosing requirements, bypass first-pass metabolism in certain cases, reduce side effects, and eliminate gastrointestinal interactions that limit bioavailability. The company's lead product candidate, TLANDO™, is an oral testosterone replacement therapy (“TRT”) and is currently under review by the United States Food and Drug Administration (“FDA”) with a Prescription Drug User Fee Act (“...

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...